New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
08:10 EDTCOV, MDTMedtronic price target raised to $73 from $66 at Oppenheimer
Oppenheimer increased its price target on Medtronic (MDT), citing cost savings and tax benefits from the company's acquisition of Covidien (COV). The firm keeps an Outperform rating on Medtronic.
News For MDT;COV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 11, 2014
09:05 EDTMDTMedtronic receives FDA approval for Attain Performa LV quadripolar leads
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use